AV Therapeutics, Inc.
company.status.inactiveCIK 1537293fmd_1AN18STZ8ST9QFV4PZ1ATAEZ30Manufacturing · Grain Mill ProductsTemplate: Standard
Coverage: Jan 01, 2007 to Sep 30, 2014, 16 periods
Latest annual · FY2013
Millions- Total revenues
- 0
- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (0)
Latest quarter · Q3 FY2014
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2010 to FY2013
- n/m
- Revenue, 5 yearsFY2008 to FY2013
- n/m
- Net income, 5 yearsFY2008 to FY2013
- n/m
AV Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2013 | FY2012 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2014-03-31 · proof | |
| Operating income | -$905,396 | -$284,343 | 10-K 2014-03-31 · proof | |
| Net income | -$905,920 | -$286,271 | 10-K 2014-03-31 · proof | |
| Cash from operating activities | -$456,184 | -$222,501 | 10-K 2014-03-31 · proof | |
| Free cash flow | -$456,184 | -$222,501 | 10-K 2014-03-31 · proof | |
| Total assets | $784,927 | $266,719 | +194.3% | 10-K 2014-03-31 · proof |
| Total liabilities | $750,755 | $547,666 | +37.1% | 10-K 2014-03-31 · proof |
| Cash and cash equivalents | $576,251 | $97,436 | +491.4% | 10-K 2014-03-31 · proof |
- What was AV Therapeutics, Inc.'s revenue in fiscal 2013?
- AV Therapeutics, Inc. reported revenue of $0 for fiscal 2013 (the year ended Dec 31, 2013), against $0 the year before. Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What was AV Therapeutics, Inc.'s operating income in fiscal 2013?
- AV Therapeutics, Inc. reported operating income of -$905,396 for fiscal 2013 (the year ended Dec 31, 2013), against -$284,343 the year before. Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What was AV Therapeutics, Inc.'s net income in fiscal 2013?
- AV Therapeutics, Inc. reported net income of -$905,920 for fiscal 2013 (the year ended Dec 31, 2013), against -$286,271 the year before. Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What was AV Therapeutics, Inc.'s cash from operating activities in fiscal 2013?
- AV Therapeutics, Inc. reported cash from operating activities of -$456,184 for fiscal 2013 (the year ended Dec 31, 2013), against -$222,501 the year before. Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What was AV Therapeutics, Inc.'s free cash flow in fiscal 2013?
- AV Therapeutics, Inc. reported free cash flow of -$456,184 for fiscal 2013 (the year ended Dec 31, 2013), against -$222,501 the year before. Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What are AV Therapeutics, Inc.'s total assets?
- As of Dec 31, 2013, AV Therapeutics, Inc. reported total assets of $784,927, against $266,719 a year earlier (+194.3%). Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What are AV Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2013, AV Therapeutics, Inc. reported total liabilities of $750,755, against $547,666 a year earlier (+37.1%). Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
- What are AV Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2013, AV Therapeutics, Inc. reported cash and cash equivalents of $576,251, against $97,436 a year earlier (+491.4%). Source: the 10-K filed with the SEC on Mar 31, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1537293&period_type=annual&limit=5"Information only, not investment advice.